Hims & Hers Health, Inc. (HIMS)Healthcare | Drug Manufacturers - Specialty & Generic | San Francisco, United States | NYSE
28.84 USD
-2.82
(-8.907%) ⇩
(Aug. 28, 2026, 4 p.m.
EDT)
After hours: 28.88 +0.04 (0.139%) ⇧ (Aug. 28, 2026, 7:59 p.m. EDT) |
Hot Take ↕ | Aug. 22, 2026, 4:32 a.m. EDT
The immediate outlook is driven by a speculative frenzy rather than fundamental stability. While the company boasts impressive top-line growth (+38%) and a massive 321% cumulative gain over the last five years, the bottom line remains broken with negative earnings and a deteriorating operating margin. The balance sheet is fragile, carrying nearly double the cash on hand in debt, which creates a significant overhang for a mature large-cap healthcare firm. However, the options market is screaming bullishness, with traders betting on a breakout past the $35-$40 resistance zone, likely fueled by anticipation of regulatory approvals for their peptide therapies. This creates a dangerous divergence: the business is still in a painful transition phase with no dividend safety net, yet the market is pricing in a 'Netflix of healthcare' scenario. For now, the momentum is strong enough to support a cautious bullish stance, but investors must ignore the ugly fundamentals and trade purely on the regulatory catalysts. |
| Model | MAE |
|---|---|
| AutoTheta ✓ | 0.107118 |
| AutoARIMA | 0.142611 |
| AutoETS | 0.142615 |
| MSTL | 0.166725 |
Forecast horizon: 45 days | Selected: AutoTheta
| Forecast Reliability | |
|---|---|
| Score | 37% |
| H-stat | 1.02 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.524 |
| Excess Kurtosis | -0.43 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 477.128 |
| Revenue per Share | 11.288 |
| Market Cap | 6,728,758,784 |
| Forward P/E | 25.88 |
| Beta | 2.42 |
| Profit Margins | -5.51% |
| Website | https://www.hims.com |
As of Aug. 22, 2026, 4:32 a.m. EDT: Speculators are aggressively positioning for a sharp upward move, evidenced by massive call volume spikes at strikes significantly above the current price (e.g., $41, $45, $50) where volume far exceeds open interest. This indicates a 'long gamma' setup expecting a rapid rally. Conversely, put writing is heavy at lower strikes ($20-$25), creating a floor, while call open interest walls at $35-$40 suggest a defined upside target. Implied volatility is elevated across the board, reflecting uncertainty around the upcoming FDA decisions and earnings report.
| Attribute | Value |
|---|---|
| 52 Week Change | -0.23765951 |
| Address1 | 2,269 Chestnut Street |
| Address2 | Suite 523 |
| All Time High | 72.98 |
| All Time Low | 2.72 |
| Ask | 28.86 |
| Ask Size | 400 |
| Audit Risk | 2 |
| Average Analyst Rating | 2.8 - Hold |
| Average Daily Volume10 Day | 12,566,620 |
| Average Daily Volume3 Month | 15,767,306 |
| Average Volume | 15,767,306 |
| Average Volume10Days | 12,566,620 |
| Beta | 2.415 |
| Bid | 28.82 |
| Bid Size | 100 |
| Board Risk | 7 |
| Book Value | 1.389 |
| City | San Francisco |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Compensation Risk | 7 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 28.84 |
| Current Ratio | 0.934 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,786,665,600 |
| Day High | 31.4 |
| Day Low | 28.52 |
| Debt To Equity | 477.128 |
| Display Name | Hims & Hers Health |
| Earnings Call Timestamp End | 1,786,395,600 |
| Earnings Call Timestamp Start | 1,786,395,600 |
| Earnings Timestamp | 1,786,392,000 |
| Earnings Timestamp End | 1,794,254,400 |
| Earnings Timestamp Start | 1,794,254,400 |
| Ebitda | -10,177,000 |
| Ebitda Margins | -0.0039500003 |
| Enterprise To Ebitda | -730.466 |
| Enterprise To Revenue | 2.883 |
| Enterprise Value | 7,433,949,696 |
| Eps Current Year | 0.53724 |
| Eps Forward | 1.11427 |
| Eps Trailing Twelve Months | -0.58 |
| Esg Populated | 0 |
| Exchange | NYQ |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 32.1724 |
| Fifty Day Average Change | -3.3324013 |
| Fifty Day Average Change Percent | -0.1035795 |
| Fifty Two Week Change Percent | -23.765951 |
| Fifty Two Week High | 65.299 |
| Fifty Two Week High Change | -36.459003 |
| Fifty Two Week High Change Percent | -0.55833936 |
| Fifty Two Week Low | 13.74 |
| Fifty Two Week Low Change | 15.1 |
| Fifty Two Week Low Change Percent | 1.0989811 |
| Fifty Two Week Range | 13.74 - 65.299 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,568,381,400,000 |
| Float Shares | 212,242,879 |
| Forward Eps | 1.11427 |
| Forward P E | 25.882418 |
| Free Cashflow | 849,437,248 |
| Full Exchange Name | NYSE |
| Full Time Employees | 2,442 |
| Fullday Change | -2.82 |
| Fullday Change Percent | -8.90714 |
| Fullday Price | 28.88 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Governance Epoch Date | 1,785,542,400 |
| Gross Margins | 0.69528997 |
| Gross Profits | 1,792,545,024 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.0561 |
| Held Percent Institutions | 0.71552 |
| Implied Shares Outstanding | 233,313,413 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Industry Disp | Drug Manufacturers - Specialty & Generic |
| Industry Key | drug-manufacturers-specialty-generic |
| Is Earnings Date Estimate | 0 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Long Business Summary | Hims & Hers Health, Inc. operates as a consumer-first health and wellness platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, Canada, Germany, the Republic of Ireland, France, Spain, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides personalized health and wellness products; over-the-counter drug and device products, cosmetics, and supplement products primarily focusing on general wellness, skincare, sexual health and wellness, and hair care under the Hims & Hers brand name; and laboratory testing services to measure a set of biomarkers. Additionally, it offers medical consultation, post-consultation support services, and delivery of laboratory testing results services. Further, the company provides treatments and products for various chronic conditions related to hormone health, weight loss, dermatology, and mental health. The company offers its products through retail partnerships, in stores, and online. Hims & Hers Health, Inc. is based in San Francisco, California. |
| Long Name | Hims & Hers Health, Inc. |
| Market | us_market |
| Market Cap | 6,728,758,784 |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_542604862 |
| Most Recent Quarter | 1,782,777,600 |
| Net Income To Common | -142,030,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 7,386,702,655 |
| Number Of Analyst Opinions | 13 |
| Open | 31.36 |
| Operating Cashflow | 263,450,000 |
| Operating Margins | -0.12751001 |
| Overall Risk | 9 |
| Payout Ratio | 0.0 |
| Peg Ratio | 2.15 |
| Phone | 415 851 0195 |
| Post Market Change | 0.03999901 |
| Post Market Change Percent | 0.13869281 |
| Post Market Price | 28.88 |
| Post Market Time | 1,787,961,597 |
| Previous Close | 31.66 |
| Price Eps Current Year | 53.681778 |
| Price Hint | 2 |
| Price To Book | 20.763138 |
| Price To Sales Trailing12 Months | 2.609956 |
| Profit Margins | -0.05509 |
| Quick Ratio | 0.82 |
| Quote Source Name | Delayed Quote |
| Quote Type | EQUITY |
| Recommendation Key | hold |
| Recommendation Mean | 2.8 |
| Region | US |
| Regular Market Change | -2.82 |
| Regular Market Change Percent | -8.90714 |
| Regular Market Day High | 31.4 |
| Regular Market Day Low | 28.52 |
| Regular Market Day Range | 28.52 - 31.4 |
| Regular Market Open | 31.36 |
| Regular Market Previous Close | 31.66 |
| Regular Market Price | 28.84 |
| Regular Market Time | 1,787,947,202 |
| Regular Market Volume | 14,658,817 |
| Return On Assets | -0.0221 |
| Return On Equity | -0.32033002 |
| Revenue Growth | 0.382 |
| Revenue Per Share | 11.288 |
| Sand P52 Week Change | 0.20504117 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Share Holder Rights Risk | 10 |
| Shares Outstanding | 224,935,790 |
| Shares Percent Shares Out | 0.2515 |
| Shares Short | 58,674,597 |
| Shares Short Previous Month Date | 1,784,073,600 |
| Shares Short Prior Month | 61,410,121 |
| Short Name | Hims & Hers Health, Inc. |
| Short Percent Of Float | 0.3023 |
| Short Ratio | 3.98 |
| Source Interval | 15 |
| State | CA |
| Symbol | HIMS |
| Target High Price | 42.0 |
| Target Low Price | 23.0 |
| Target Mean Price | 31.23077 |
| Target Median Price | 31.0 |
| Total Cash | 841,048,000 |
| Total Cash Per Share | 3.605 |
| Total Debt | 1,546,238,976 |
| Total Revenue | 2,578,112,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -0.58 |
| Trailing Peg Ratio | 2.1549 |
| Triggerable | 1 |
| Two Hundred Day Average | 28.66635 |
| Two Hundred Day Average Change | 0.17365074 |
| Two Hundred Day Average Change Percent | 0.0060576512 |
| Type Disp | Equity |
| Volume | 14,658,817 |
| Website | https://www.hims.com |
| Zip | 94,123 |